Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Molly Lederman, M.D.

Concepts (26)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vancomycin120175010.230 Why?
Drug Monitoring120179560.190 Why?
Guideline Adherence1201722660.140 Why?
Anti-Bacterial Agents2201771810.110 Why?
Cephalexin12013370.110 Why?
Quality Improvement1201737490.100 Why?
Cellulitis120132060.100 Why?
Dose-Response Relationship, Drug12017109430.030 Why?
Staphylococcal Skin Infections12013750.030 Why?
Child, Preschool22017410060.020 Why?
Methicillin-Resistant Staphylococcus aureus120136870.020 Why?
Infant12017351360.020 Why?
Child22017777090.010 Why?
Adolescent22017857810.010 Why?
Drug Therapy, Combination1201364890.010 Why?
Prospective Studies12017532880.010 Why?
Double-Blind Method12013120260.010 Why?
Retrospective Studies12017774490.010 Why?
Male120173501180.010 Why?
Female120173801940.000 Why?
Humans220177443430.000 Why?
Young Adult12013564300.000 Why?
Treatment Outcome12013631140.000 Why?
Aged120131632800.000 Why?
Middle Aged120132133830.000 Why?
Adult120132140550.000 Why?
Lederman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (26)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.